Pacira BioSciences (PCRX) Shares Outstanding (Entity) (2010 - 2026)
Powered by 
Analysis
Pacira BioSciences (PCRX) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.35 Bn | 624.59 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 440.82 Bn | 434.25 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 364.35 Bn | 357.21 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 266.35 Bn | 258.66 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.92 Bn | 147.22 Bn | 10.94 Bn | 5.70 Bn |
| 6 | Sanofi | 52.51 Bn | 45.13 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.21 Bn | 44.21 Bn | - | 214.24 Mn |
| 8 | Incyte | 25.30 Bn | 20.76 Bn | 1.57 Bn | 200.98 Mn |
| 9 | United Therapeutics | 21.40 Bn | 18.73 Bn | 683.80 Mn | 42.68 Mn |
| 10 | Pacira BioSciences | 1.01 Bn | 757.82 Mn | 148.24 Mn | 39.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.82 Mn |
| Mar 31, 2026 | 39.31 Mn |
| Dec 31, 2025 | 41.12 Mn |
| Sep 30, 2025 | 42.97 Mn |
| Jun 30, 2025 | 44.90 Mn |
| Mar 31, 2025 | 46.28 Mn |
| Dec 31, 2024 | 46.24 Mn |
| Sep 30, 2024 | 46.15 Mn |
| Jun 30, 2024 | 46.12 Mn |
| Mar 31, 2024 | 46.52 Mn |
| Dec 31, 2023 | 46.48 Mn |
| Sep 30, 2023 | 46.43 Mn |
| Jun 30, 2023 | 46.41 Mn |
| Mar 31, 2023 | 45.97 Mn |
| Dec 31, 2022 | 45.93 Mn |
| Sep 30, 2022 | 45.86 Mn |
| Jun 30, 2022 | 45.80 Mn |
| Mar 31, 2022 | 45.06 Mn |
| Dec 31, 2021 | 44.73 Mn |
| Sep 30, 2021 | 44.52 Mn |